Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

KORU Medical Systems (KRMD) Change in Account Payables (2020 - 2025)

KORU Medical Systems (KRMD) has disclosed Change in Account Payables for 11 consecutive years, with $777623.0 as the latest value for Q3 2025.

  • On a quarterly basis, Change in Account Payables rose 942.26% to $777623.0 in Q3 2025 year-over-year; TTM through Sep 2025 was $201862.0, a 72.14% decrease, with the full-year FY2024 number at $674776.0, up 147.63% from a year prior.
  • Change in Account Payables was $777623.0 for Q3 2025 at KORU Medical Systems, up from -$919038.0 in the prior quarter.
  • In the past five years, Change in Account Payables ranged from a high of $1.3 million in Q1 2021 to a low of -$1.0 million in Q3 2022.
  • A 5-year average of $65644.3 and a median of $40447.0 in 2022 define the central range for Change in Account Payables.
  • Peak YoY movement for Change in Account Payables: crashed 2297.14% in 2023, then soared 942.26% in 2025.
  • KORU Medical Systems' Change in Account Payables stood at -$157880.0 in 2021, then skyrocketed by 749.98% to $1.0 million in 2022, then crashed by 97.12% to $29574.0 in 2023, then plummeted by 168.75% to -$20331.0 in 2024, then surged by 3924.81% to $777623.0 in 2025.
  • Per Business Quant, the three most recent readings for KRMD's Change in Account Payables are $777623.0 (Q3 2025), -$919038.0 (Q2 2025), and $363608.0 (Q1 2025).